New York Senate Bill S03350

New York 2023-2024 Regular Session

• Introduced: 1/30/23
• Refer: 1/30/23
• Refer: 1/3/24

Caption

Requires practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry.